Uncategorized
Global Ophthalmology Drugs Market to 2023 – Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads the Research Landscape – Research and Markets
DUBLIN--(BUSINESS WIRE)--The "Global Ophthalmology Drugs Market to 2023 - Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads the Research Landscape" report has been added to Research and Markets' offering. The ophthalmology market is forecast to grow at a compound annual growth rate (CAGR) of 6.7% till 2023 - with the majority of this growth expected to occur in the final four years of the forecast period. Of the five key indications wit